Mnemonic of Principles for Effective Specialist-Generalist Conferences: The BRIDGE. [PDF]
J Gen Fam MedJournal of General and Family Medicine, Volume 27, Issue 2, March 2026.
Kanzawa Y +8 more
europepmc +2 more sources
The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy [PDF]
Ann Am Thorac Soc, 2018 Previously we reported that mithramycin represses multiple pathways critical for stem cell signaling and pluripotency in lung cancer cells.
Zhang M +8 more
europepmc +3 more sources
Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation [PDF]
Journal of Experimental & Clinical Cancer Research, 2017 Background Although previous studies have shown promise for targeting Musashi RNA-binding protein 2 (MSI-2) in diverse tumors, the role and mechanism of MSI-2 for cervical cancer (CC) progression and the regulation of MSI-2 expression remains unclear ...
Peixin Dong +4 more
doaj +2 more sources
Capacity of Human Dental Follicle Cells to Differentiate into Neural Cells In Vitro [PDF]
Stem Cells International, 2017 The dental follicle is an ectomesenchymal tissue surrounding the developing tooth germ. Human dental follicle cells (hDFCs) have the capacity to commit to differentiation into multiple cell types.
Shingo Kanao +6 more
doaj +4 more sources
Increased musashi 2 expression indicates a poor prognosis and promotes malignant phenotypes in gastric cancer. [PDF]
Oncol Lett, 2019 Musashi 2 (MSI2), a marker of stem and progenitor cells, has been identified as an oncogene. Various investigations have revealed that MSI2 is differently expressed in several types of blood cancer and solid cancers. However, its expression and biological functions in gastric cancer (GC) remain unclear.
Yang Z, Li J, Shi Y, Li L, Guo X.
europepmc +4 more sources
DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer. [PDF]
Oncogene, 2017 The gene encoding 'deleted in breast cancer 2' (DBC2), also referred to as RHOBTB2 (Rho-related BTB domain-containing protein 2), is classified as a tumor suppressor gene. DBC2 is a substrate-specific adaptor protein for a novel class of Cullin-3 (CUL3)-based E3 ubiquitin ligases; however, it is unclear if the substrate adaptor function of DBC2 is ...
Choi YM +6 more
europepmc +4 more sources
Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis [PDF]
International Journal of Molecular Sciences, 2022 Theresa Strauß +2 more
exaly +2 more sources
Time From Initial Community-Based Dementia Consultation to Confirmed Diagnosis: A Retrospective Analysis. [PDF]
PsychogeriatricsABSTRACT Background With the launch of anti‐amyloid beta antibody drugs, physicians face the need to quickly diagnose dementia. In prehospital consultation services in Japan, the duration from memory‐related consultations to confirmed diagnosis has not been sufficiently investigated.
Yamazaki A +3 more
europepmc +2 more sources
MUSASHI-2 duels in myelodysplastic syndromes. [PDF]
Cell Cycle, 2016 Ho TC, Taggart J, Kharas MG.
europepmc +4 more sources
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC). [PDF]
Oncogenesis, 2021 Non-small cell lung cancer (NSCLC) has limited treatment options. Expression of the RNA-binding protein (RBP) Musashi-2 (MSI2) is elevated in a subset of non-small cell lung cancer (NSCLC) tumors upon progression, and drives NSCLC metastasis.
Makhov P +22 more
europepmc +3 more sources